Article
In vivo Treatment of a Severe Vascular Disease via a Bespoke CRISPR-Cas9 Base Editor
medRxiv · 2024 · Alves, C. R. R.; Das, S.; Krishnan, V.; Ha, L. L.; Fox, L. R.; Stutzman, H. E.; Shamber, C. E.; Kalailingam, P.; McCarthy, S.; Lino Cardenas, C. L.; Fong, C. E.; Imai, T.; Mitra, S.; Yun, S.; Wood, R. K.; Benning, F. M. C.; Lawton, J.; Kim, N.; Silverstein, R. A.; Ferreira da Silva, J.; de la Cruz, D.; Richa, R.; Malhotra, R.; Chung, D. Y.; Chao, L. H.; Tsai, S. Q.; Maguire, C. A.; Lindsay, M. E.; Kleinstiver, B. P.; Musolino, P. L.
Key facts
| Title | In vivo Treatment of a Severe Vascular Disease via a Bespoke CRISPR-Cas9 Base Editor |
|---|---|
| First author | Alves, C. R. R.; Das, S.; Krishnan, V.; Ha, L. L.; Fox, L. R.; Stutzman, H. E.; Shamber, C. E.; Kalailingam, P.; McCarthy, S.; Lino Cardenas, C. L.; Fong, C. E.; Imai, T.; Mitra, S.; Yun, S.; Wood, R. K.; Benning, F. M. C.; Lawton, J.; Kim, N.; Silverstein, R. A.; Ferreira da Silva, J.; de la Cruz, D.; Richa, R.; Malhotra, R.; Chung, D. Y.; Chao, L. H.; Tsai, S. Q.; Maguire, C. A.; Lindsay, M. E.; Kleinstiver, B. P.; Musolino, P. L. |
| Journal | medRxiv |
| Published | Jan 1, 2024 |
| DOI | 10.1101/2024.11.11.621817 |
| Devices mentioned | K010696 |
| Product codes mentioned | JIS, JJH, PFF, PFT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1